Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 17, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories, Inc. (CML) is pleased to announce the appointment of Dr. Mark Sawicki as Chief Business Officer. With executive leadership responsibility for the global sales and marketing ...
read more
Thursday, September 12, 2013
FlowMetric, a market leader in flow cytometry and cell sorting services, announced today that they are expanding their global capacity with the launch of a European laboratory facility located at the Parco Tecnologico Padano in Lodi, Italy. Since its...
read more
Tuesday, September 10, 2013
Almac today announced they are now offering a Tumor Profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor™ panel as part of their biomarker discovery, development and delivery solutions.
read more
Friday, September 06, 2013
MPI Research, in partnership with INVICRO and 3D Imaging, today held the groundbreaking for its new world-class Imaging Center, set to open in spring 2014 at the MPI Research global corporate headquarters in Mattawan, Mich. For the first time, ...
read more
Tuesday, September 03, 2013
Sigma-Aldrich® Corporation's BioReliance® (www.bioreliance.com), the biologics and early-development services business under SAFC® (www.sigmaaldrich.com/safc), has qualified the Big Blue® Mouse Transgenic Rodent Mutation (TRM) assay to meet the new ...
read more
Thursday, August 22, 2013
A workshop to discuss ways of improving the quality of drugs entering into the preclinical stage of development will be led by Ciriaco Maraschiello, PhD, director of drug discovery and translational medicines for Harlan Contract Research Services (...
read more
To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging...
read more
Thursday, August 15, 2013
Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, Inc. for the investigation of the biological mechanism of action of a ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed David Johnston, Ph.D., as executive vice president of global laboratory services. Dr. Johnston directs PPD’s industry-leading, comprehensive laboratory services, including...
read more
Thursday, August 08, 2013
Harlan Contract Research Services (CRS) Cytotest Cell Research GmbH in Rossdorf, Germany, has been named one of the first laboratories selected for inclusion in the European Union Network of Laboratories for the Validation of Alternative Methods (EU-...
read more
Thursday, August 08, 2013
Vindon, an international company specializing in controlled storage technology for the pharma and biopharma industries, has opened a new facility in Los Angeles, Southern California.
read more
Apoptosis, or programmed cell death, is used by the body to remove unwanted, damaged or senescent cells from tissues. Gentronix, specialists in genotoxicity testing, announces the expansion of its service testing portfolio with the launch of ...
read more
AIT Laboratories (AIT) announces the appointment of R. Matthew Neff as President and Chief Executive Officer of the company, effective August 5, 2013. Neff will also remain in his role as Chairman of the Board for the company. Dr. Michael Evans, the...
read more
Thursday, August 01, 2013
Serina Therapeutics, Inc., a pharmaceutical research and development company that has developed a proprietary, patented polymer technology for drug development, announced today that the company has entered into a research agreement with the Scripps ...
read more
MRIGlobal and Evogen Inc. today announced that they have agreed to a strategic collaboration to develop advanced molecular diagnostics products, targeted to support in vitro and clinical molecular diagnostics markets.
read more